On September 14, China Medical City and China Pharmaceutical University held a signing ceremony of strategic cooperation agreement, which marked a new chapter of cooperation between two sides and would play a catalytic role in further deepening industry-university-research institute cooperation of Taizhou, accelerate the construction of talent support system and constantly improve the construction of innovation system. Qu Futian, Secretary of the CPC Taizhou Municipal Committee, and Lai Maode, President of China Pharmaceutical University, attended the ceremony.
According to the agreement, two sides will plan to co-build a platform for research and development, encourage scientific research personnel of the China Pharmaceutical University to carry out research achievement transformation on the platform, promote industrial upgrading by scientific and technological innovation, and make efforts to improve the technical level of regional industry and independent innovation ability. Both sides will work together to build the off-campus practice base for students, and continuously promote talent training of pharmaceutical higher education. In addition, China Pharmaceutical University will provide training opportunities for the in-service personnel of China Medical City in accordance with the actual needs and within the allowed bounds of policy, and promote the quality and ability of in-service personnel in an all-round way.
Qu Futian pointed out that top universities and institutes were the most important innovation infrastructures and the most important high-end carriers. The overall strategic cooperation of China Medical City and China Pharmaceutical University will set a new benchmark for Taizhou to further promote the cooperation of industry, academia and research, and inject new impetus for accelerating the construction of the talent highland of the medical industry. China Medical City should make full use of the education, scientific researches and human resources of China Pharmaceutical University, aim at key fields and links such as medical research and development, health services and so on, and achieve new and greater breakthroughs. He hoped that China Pharmaceutical University could take advantage of agglomeration of the bioengineering and pharmaceutical industry of the China Medical City, improve the ability of scientific research and personnel training with mutually beneficial cooperation, and promote the high-end development of Taizhou bioengineering and pharmaceutical industry.